Primary cutaneous B-cell lymphomas – Clinicopathological, prognostic and therapeutic characterisation of 54 cases according to the WHO-EORTC classification and the ISCL/EORTC TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome
- 1 January 2008
- journal article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 49 (6) , 1094-1103
- https://doi.org/10.1080/10428190802064925
Abstract
Clinical, prognostic and therapeutic features of 54 primary cutaneous marginal zone B-cell lymphoma (pcMZL), follicle centre lymphoma (pcFCL) and diffuse large B-cell lymphoma, leg type (pcDLBL) were analysed applying the WHO-EORTC classification for cutaneous lymphomas and the new TNM staging scheme of the International Society of Cutaneous Lymphomas. Solitary (T1) or regionally clustered (T2) tumors were observed in pcMZL and pcFCL. Disseminated tumors (T3 stage) were found in 26% of patients with pcMZL and in one patient with pcDLBL. A complete remission was achieved in 41% of the patients. Three of 7 patients (43%) with pcDLBL died due to lymphoma. The new TNM staging system is easily applicable for disease documentation, but our relatively small number of patients in each T stage does not allow the assessment of its prognostic value. Surgical excision or radiotherapy is highly effective in pcMZL and pcFCL.Keywords
This publication has 19 references indexed in Scilit:
- The applicability and prognostic value of the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: results on a large cohort of primary cutaneous B-cell lymphomas and comparison with the system used by the Dutch Cutaneous Lymphoma GroupBritish Journal of Dermatology, 2007
- TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC)Blood, 2007
- Reclassification of 300 Primary Cutaneous B-Cell Lymphomas According to the New WHO–EORTC Classification for Cutaneous Lymphomas: Comparison With Previous Classifications and Identification of Prognostic MarkersJournal of Clinical Oncology, 2007
- Intra-lesional low-dose interferon α2a therapy for primary cutaneous marginal zone B-cell lymphomaLeukemia & Lymphoma, 2006
- Primary Cutaneous Marginal Zone B-Cell LymphomaArchives of Dermatology, 2005
- WHO-EORTC classification for cutaneous lymphomasBlood, 2005
- Adenovirus-mediated intralesional interferon-γ gene transfer induces tumor regressions in cutaneous lymphomasBlood, 2004
- Primary Cutaneous Follicular LymphomaThe American Journal of Surgical Pathology, 2002
- Infection by Borrelia burgdorferi and cutaneous B‐cell lymphomaJournal of Cutaneous Pathology, 1997
- Primary cutaneous follicular centre-cell lymphoma-a lymphoproliferative disease with favourable prognosisClinical and Experimental Dermatology, 1989